Jay H. Knight


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.


Jay Knight is head of the firm’s Capital Markets Subgroup. His practice focuses on securities offerings, mergers and acquisitions, real estate capital markets, structured finance, and the general representation of public companies and underwriters. Since his return to private practice in 2012 after having served five years in the Securities and Exchange Commission’s (SEC) Division of Corporation Finance, Jay has represented both issuers and underwriters in connection with initial public offerings (IPOs), follow-on and secondary offerings, tender offers, and mergers and acquisitions, involving companies in a wide range of industries, including healthcare, real estate (REITs), defense and restaurant. During this time, he has also led a team that has served as counsel on more than 50 SEC-registered commercial mortgage-backed securities transactions that involved collateral valued in excess of $75 billion.

In 2016, Jay Knight and the team at Bass, Berry & Sims were recognized by The M&A Advisor in conjunction with the firm’s representation of Community Health Systems, Inc. (NYSE: CYH) in connection with its spin-off of Quorum Health Corporation. This transaction was named a finalist by The M&A Advisor in four categories, including “Healthcare and Life Sciences Deal of the Year (over $100MM)” and “M&A Deal of the Year in the over $1 billion – $5 billion.” Jay is active in the leadership of the ABA’s Federal Regulation of Securities Committee, including serving as the Chair of the Annual Review of Securities Law Subcommittee and its high profile annual survey of securities law developments in rulemaking, litigation and accounting, and has been published on securities matters in leading periodicals such as The Corporate Executive. Jay has also been published or quoted by numerous national news outlets on securities issues, including in published articles by The Wall Street Journal, American Banker, Law360, CFO.com and others.

Read More

Featured Experience


American Bar Association — Business Law Section

  • Vice Chair, Federal Regulation of Securities Committee (2018 – present)
  • Securities Registration and Corporate Governance Subcommittees (2012 – present)
  • Chair of Annual Review of Securities Law Subcommittee (2015 – 2018)
  • Drafting Subcommittee on the Section 12(g) Crowdfunding Exemption (2015)
  • Drafting Subcommittee on the Crowdfunding Proposed Rule, Co-chair (2014)

National Association of Real Estate Investment Trust (NAREIT) — Government Relations Committee (2012 – present)

American Health Lawyers Association (AHLA)